Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (291-300 of 675) with videos related to

Pageof 68
Sort By:
Journal of Hematology & Oncology|April 5, 2018
Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE studyMeletios Dimopoulos, Michael Wang, Vladimir Maisnar, et al.
Computing and Software for Big Science|October 30, 2023
Accelerating Machine Learning Inference with GPUs in ProtoDUNE Data ProcessingTejin Cai, Kenneth Herner, Tingjun Yang, et al.
Seminars in Nuclear Medicine|March 27, 2026
Structured reading for Tau PET Imaging in Alzheimer's disease and related dementiasAkintunde T Orunmuyi, Michael Wang, Antoine Rogeau, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Synthesis and biological evaluation of phosphonate analogues of nevirapineJay Parrish, Leah Tong, Michael Wang, et al.
STAR Protocols|March 4, 2022
An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic responseYing-Nai Wang, Heng-Huan Lee, Yongkun Wei, et al.
Biomarker Research|June 17, 2024
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphomaVivian Jiang, William Lee, Tianci Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2024
Retrospective chart review of GI bleeding in people with von Willebrand diseaseJonathan C Roberts, Miguel A Escobar, Suchitra Acharya, et al.
American Journal of Hematology|May 12, 2020
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myelomaElisabet E Manasanch, Preetesh Jain, Wendy Chen, et al.
The American Journal of Surgical Pathology|May 3, 2019
CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 PatientsYuan Miao, Pei Lin, Annapurna Saksena, et al.
Blood|August 28, 2009
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosisYuhuan Zheng, Zhen Cai, Siqing Wang, et al.
Pageof 68

Showing results (291-300 of 675) with videos related to

Sort By:
Pageof 68
Journal of Hematology & Oncology|April 5, 2018
Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE studyMeletios Dimopoulos, Michael Wang, Vladimir Maisnar, et al.
Computing and Software for Big Science|October 30, 2023
Accelerating Machine Learning Inference with GPUs in ProtoDUNE Data ProcessingTejin Cai, Kenneth Herner, Tingjun Yang, et al.
Seminars in Nuclear Medicine|March 27, 2026
Structured reading for Tau PET Imaging in Alzheimer's disease and related dementiasAkintunde T Orunmuyi, Michael Wang, Antoine Rogeau, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Synthesis and biological evaluation of phosphonate analogues of nevirapineJay Parrish, Leah Tong, Michael Wang, et al.
STAR Protocols|March 4, 2022
An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic responseYing-Nai Wang, Heng-Huan Lee, Yongkun Wei, et al.
Biomarker Research|June 17, 2024
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphomaVivian Jiang, William Lee, Tianci Zhang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 16, 2024
Retrospective chart review of GI bleeding in people with von Willebrand diseaseJonathan C Roberts, Miguel A Escobar, Suchitra Acharya, et al.
American Journal of Hematology|May 12, 2020
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myelomaElisabet E Manasanch, Preetesh Jain, Wendy Chen, et al.
The American Journal of Surgical Pathology|May 3, 2019
CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 PatientsYuan Miao, Pei Lin, Annapurna Saksena, et al.
Blood|August 28, 2009
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosisYuhuan Zheng, Zhen Cai, Siqing Wang, et al.
Pageof 68